Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
06/2003
06/11/2003EP1317453A1 Isoxazoles and their use as inhibitors of erk
06/11/2003EP1317452A1 Pyrazole compounds useful as protein kinase inhibitors
06/11/2003EP1317450A1 Pyrazole compounds useful as protein kinase inhibitors
06/11/2003EP1317449A1 Pyrazole compounds useful as protein kinase inhibitors
06/11/2003EP1317448A1 Pyrazole compounds useful as protein kinase inhibitors
06/11/2003EP1317447A1 Pyrazole compounds useful as protein kinase inhibitors
06/11/2003EP1317444A1 Pyrazole compounds useful as protein kinase inhibitors
06/11/2003EP1317443A2 Chemokine receptor binding heterocyclic compounds
06/11/2003EP1317433A2 Inhibitors of glycogen synthase kinase 3
06/11/2003EP1317432A1 Piperidine derivatives for use as 2,3-oxidosqualene-lanosterol cyclase inhibitors
06/11/2003EP1317431A2 Polyarylcarboxamides useful as lipid lowering agents
06/11/2003EP1317428A1 Pyrrolidine-2-carboxylic acid hydrazide derivatives for use as metalloprotease inhibitors
06/11/2003EP1317421A1 2-amino-2-alkyl-5 heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors
06/11/2003EP1317420A1 2-amino-2-alkyl-3 hexenoic and hexynoic acid derivatives useful as nitric oxide synthase inhibitors
06/11/2003EP1317417A2 2-amino-2-alkyl-3 heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors
06/11/2003EP1317414A2 Gamma-ketoacid dipeptides as inhibitors of caspase-3
06/11/2003EP1317413A1 Substituted biphenyl derivatives, method for preparing same and pharmaceutical compositions containing same
06/11/2003EP1317283A2 Tweak receptor agonists as anti-angiogenic agents
06/11/2003EP1317265A2 Method for diagnosing neuronal diseases and for treating primary hemostasis deficiency
06/11/2003EP1317264A2 Combination of lipoic acids and conjugated acids for treating diabetic disorders
06/11/2003EP1317190A2 Supplement for type 2 diabetes or lipodystrophy
06/11/2003EP1131065B1 Dialkylfumarates for the treatment of autoimmune diseases
06/11/2003EP1054012B1 Purine derivatives and adenosine a2 receptor antagonists serving as preventives/remedies for diabetes
06/11/2003EP1021413B1 The preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
06/11/2003EP0966462B1 Heterocyclic compounds useful as oxido-squalene cyclase inhibitors
06/11/2003EP0750511B1 Treating inflammation via the administration of specific sulfatase enzymes and/or sulfation inhibitor
06/11/2003CN1423700A Multifunctional polypeptides comprising a binding site to and epitope of the NKG2D receptor complex
06/11/2003CN1423693A Method for the production of vitamin A
06/11/2003CN1423657A Inter feron-alpha induced gene
06/11/2003CN1423647A Beta-alanine derivatives and their use as receptor antagonists
06/11/2003CN1423646A Hetero cyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents
06/11/2003CN1423645A 维他命d类似物 Vitamin d analogues
06/11/2003CN1423640A 8,8a-dihydro-indeno [1,2-d] thiazole derivatives, substituted in position 8a, a method for their production and their use as medicaments, e.g. anorectic agents
06/11/2003CN1423639A Solid state forms of 5-[[6-[(2-Fluorophenyl) methoxy]-2-naphthalenyl] methyl]-2,4-Thiazolidinedione
06/11/2003CN1423637A Novel substituted tricyclic compounds
06/11/2003CN1423634A Polymorphic form of atorvastain calcium
06/11/2003CN1423633A Azetidine derivatives, preparation thereof and pharmaceutical compositions
06/11/2003CN1423627A 维生素d类似物 Vitamin d analogues
06/11/2003CN1423566A 体重增加抑制剂 Weight gain inhibitor
06/11/2003CN1423563A Pancreatic stem cells and their use in transplantation
06/11/2003CN1423528A Nutritional modules
06/11/2003CN1422859A Reaction method of biological alkali, reaction product and use thereof
06/11/2003CN1422849A 吲唑衍生物 Indazole derivative
06/11/2003CN1422654A Chinese medicine fat-reducing liniment and preparation method thereof
06/11/2003CN1422638A Antang capsule formula
06/11/2003CN1422634A Formula of Sumei fat-reducing plaster and production technology
06/11/2003CN1422627A Medicine for treating blood fat abnormal and its preparation method
06/11/2003CN1422614A Soluble L-calcium lactate preparation and preparing method
06/11/2003CN1422612A Nano-grade medicine controlled-releasing technology and preparation and use for viformicoid preparation
06/11/2003CN1111067C Preparation of freeze-dried spirulina powder containing diabetes resisting factor
06/10/2003US6576793 β2-adrenergic receptor agonists
06/10/2003US6576666 First fatty acid compound that is a linoleic or linolenic compound and a second fatty acid that is a docosahexaenoic acid compound, an omega-3 or an omega-2 fatty acid or derivative
06/10/2003US6576660 Methods and compositions for regulation of 5-α-reductase activity
06/10/2003US6576653 Bicyclic pyrrolyl amides as glycogen phosphorylase inhibitors
06/10/2003US6576648 Compound with growth hormone releasing properties
06/10/2003US6576644 Treating sexual dysfunction including erectile dysfunction, diabetes melitus, gastrointestinal disorders, including gastric paresis and cardiovascular disorders; cyclic guanosine 3',5'-monophosphate (cGMP)
06/10/2003US6576640 Rapidly penetration into central nervous system; treating noradrenaline deficiency; depression, Parkinson's disease
06/10/2003US6576630 Compounds and compositions as protease inhibitors
06/10/2003US6576270 Herbal composition and medicament against diabetes mellitus type II manufactured thereof
06/10/2003US6576242 Compositions and methods for reducing or controlling blood cholesterol, lipoproteins, triglycerides and atherosclerosis
06/10/2003CA2204437C Novel compositions based on a synergistic combination of one or more vrd ligands and retinoids
06/10/2003CA2200651C Sodium alendronate preparation for local administration
06/10/2003CA2192354C Corticotropin releasing factor against antagonist
06/10/2003CA2189603C Propiophenone derivative and processes for preparing the same
06/10/2003CA2093510C Oxysulfonyl carbamates
06/10/2003CA2054619C Aminocoumaran derivatives, their production and use
06/06/2003CA2413479A1 Kit for reducing aching
06/05/2003WO2003046576A1 Fibrinogen biopolymer marker and its use for the screening of type ii diabetes
06/05/2003WO2003046575A1 Biopolymer marker indicative of normal human
06/05/2003WO2003046574A2 Complement c3 precursor biopolymer markers indicative of insulin resistance
06/05/2003WO2003046556A2 Globin biopolymer markers indicative of insulin resistance
06/05/2003WO2003046135A2 Osteopontin-related compositions and methods
06/05/2003WO2003046010A1 Inter alpha trypsin inhibitor biopolymer markers indicative of insulin resistance
06/05/2003WO2003045999A2 Human vanilloid receptor protein and polynucleotide sequence encoding same
06/05/2003WO2003045994A1 Novel ligand and dna thereof
06/05/2003WO2003045993A2 Protein biopolymer markers predictive of type ii diabetes
06/05/2003WO2003045984A2 Fibronectin and fibrinogen biopolymer markers indicative of insulin resistance
06/05/2003WO2003045983A1 Apolipoprotein biopolymer markers predictive of type ii diabetes
06/05/2003WO2003045977A2 Peptidomimetic Inhibitors of Post-Proline Cleaving Enzymes
06/05/2003WO2003045974A2 Methods and compositions for derepression of iap-inhibited caspase
06/05/2003WO2003045967A1 Aryl fused azapolycyclic compounds
06/05/2003WO2003045955A1 Use of selective potassium channel openers
06/05/2003WO2003045954A1 Use of selective potassium channel openers
06/05/2003WO2003045947A1 Rosiglitazone edisylates and their use as antidiabetics
06/05/2003WO2003045946A1 5-(4-(2-(n-methyl-n-(2-pyridil) amino) ethoxy) benzyl) thiazolidine-2, 4-dione benzenesulfonate; process for its preparation; polymorphs i, ii and iii thereof; and its use as pharmaceutical active ingredient
06/05/2003WO2003045945A1 5-(4-(2-(n-methyl-n-(2-pyridyl)amido)ethoxy)benzyl)thiazolidine-2,4-dione and pharmaceutical compositions comprising the same
06/05/2003WO2003045944A1 Aromatic sulfone hydroxamic acids and their use as protease inhibitors
06/05/2003WO2003045942A2 Chemokine receptor antagonists and methods of use thereof
06/05/2003WO2003045926A1 5-sulphanyl-4h-1,2,4-triazole derivatives and their use as medicine
06/05/2003WO2003045921A1 Heterocyclic amide compounds as apolipoprotein b inhibitors
06/05/2003WO2003045920A1 4-aminoquinoline compounds
06/05/2003WO2003045918A1 Piperidine-based mch antagonists for treatment of obesity and cns disorders
06/05/2003WO2003045912A1 Inhibitors of factor xa and other serine proteases involved in the coagulation cascade
06/05/2003WO2003045902A1 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases
06/05/2003WO2003045582A1 Metallic structures incorporating bioactive materials and methods for creating the same
06/05/2003WO2003045437A1 Pharmaceutical compositions of 5,7,14-triazatetracyclo[10.3.1.0(2,11).0(4,9)]-hexadeca-2(11)3,5,7,9-pentaene
06/05/2003WO2003045424A1 Methods of compositions for normalizing lipid levels in mammalian tissues
06/05/2003WO2003045422A1 Agonists and antagonists of prolixin for the treatment of metabolic disorders
06/05/2003WO2003045421A1 Agonists and antagonists of ryzn for the treatment of metabolic disorders
06/05/2003WO2003045411A2 Ginger extract preparation
1 ... 898 899 900 901 902 903 904 905 906 907 908 909 910 911 912 913 914 915 916 917 918 ... 1298